Host Defense Peptides: Unveiling New Roles in Blood Clotting and Vessel Health

Host Defense Antimicrobial Peptides (HDPs) are widely recognized for their crucial roles in the innate immune system, primarily through their direct antimicrobial activity against pathogens. However, their physiological functions extend far beyond pathogen defense, with growing evidence suggesting their involvement in complex regulatory networks. There has been a significant gap in understanding the specific mechanisms and comprehensive impact of HDPs on hemostasis (the process of stopping bleeding) and overall vascular biology.

The review revealed that HDPs exert diverse and context-dependent effects on hemostasis, acting as both pro-coagulant (promoting clotting) and anti-coagulant (inhibiting clotting) agents, depending on the specific peptide, concentration, and physiological environment. They found HDPs can directly interact with platelets, significantly influencing their aggregation and activation, and modulate the activity of key coagulation factors. Furthermore, HDPs were shown to impact fibrinolysis (the enzymatic breakdown of blood clots) and play a crucial role in regulating endothelial cell function, which is vital for maintaining vascular integrity and preventing disease. The most significant finding was the identification of HDPs as critical, previously underappreciated, regulators of both blood clotting and the overall health of blood vessels, suggesting a complex and intricate interplay beyond their traditional immune roles. These peptides were also observed to influence angiogenesis (the formation of new blood vessels) and modulate vascular inflammation, indicating their broad and profound impact on cardiovascular health and disease progression.